Literature DB >> 447412

A comparison of two in vitro methods for studying a defect in leucocyte movement in rheumatoid arthritis.

J R Walker, M J Smith, D W James.   

Abstract

Filter and agarose plate techniques have been used to study an abnormality of polymorphonuclear leucocyte movement in patients with rheumatoid arthritis. The chemotactic response of normal cells towards activated rheumatoid plasma was significantly less than that towards activated control plasma when examined in Boyden chambers. This defect was not observed using the agarose plate method where the response of both control and rheumatoid cells towards activated rheumatoid plasma was identical. The existence of the plasma defect, which has been shown to be cell-directed, would not have been apparent had the agarose plate method been used alone. The choice of suitable in vitro methodologies for studying leucocyte movement in pathological conditions is therefore of some importance.

Entities:  

Mesh:

Year:  1979        PMID: 447412     DOI: 10.1159/000232279

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  4 in total

1.  Staphylococcal infections in childhood dermatomyositis--association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defect.

Authors:  E C Moore; F Cohen; S D Douglas; V Gutta
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

2.  Analysis of the linear under-agarose leukocyte chemotaxis assay.

Authors:  C Rothman; D Lauffenburger
Journal:  Ann Biomed Eng       Date:  1983       Impact factor: 3.934

3.  An inhibitor of leucocyte movement in the plasma of patients with rheumatoid arthritis.

Authors:  J R Walker; M J Smith
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

4.  Neutrophil functions and clinical performance after total fasting in patients with rheumatoid arthritis.

Authors:  A M Udén; L Trang; N Venizelos; J Palmblad
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.